Log In
BCIQ
Print this Print this
 

LEO 43204

  Manage Alerts
Collapse Summary General Information
Company Leo Pharma A/S
DescriptionNot disclosed
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I/II
Standard IndicationActinic keratosis
Indication DetailsTreat actinic keratosis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today